Skip to content

The predictive value of APOC3 for myocardial injury after ischemia-reperfusion injury

The predictive value of APOC3 for myocardial injury after ischemia-reperfusion injury

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091959
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-11-08
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury after ischemia-reperfusion

Interventions

Myocardial injury group:Nothing
Non myocardial injury group:Nothing

Sponsors

Guangdong Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Eligible patients are required to be between 18 and 90 years old and undergo the following elective open heart surgery alone: coronary artery bypass surgery; Aortic valve, mitral valve or tricuspid valve replacement or repair surgery; Aortic root or ascending aorta surgery without low-temperature circulatory arrest; Or maze radiofrequency ablation.

Exclusion criteria

Exclusion criteria: Including emergency surgery; Infections expected to affect postoperative recovery; Persistent heart failure or low output syndrome ;Syndromes (pre determined significant positive muscle strength support, mechanical ventilation, extracorporeal membrane oxygenation support, aortic bulb) ;Balloon counterpulsation, left ventricular mechanical assistance, left ventricular ejection fraction below 20%, or other similar preoperative conditions; End stage renal disease (estimated glomerular filtration rate [GFR]<20mL/min); Hemophilia A or B; The patient refuses blood products or derivatives; Use ticagrelor, prasugrel, clopidogrel, apixaban or rivaroxaban within 2 days before surgery, or use dabigatran within 3 days before surgery.

Design outcomes

Primary

MeasureTime frame
Apolipoprotein C-?;

Secondary

MeasureTime frame
Creatine Kinase, MB Form;Total Cholesterol;Triglycerides ;Low-Density Lipoprotein Cholesterol;High-Density Lipoprotein Cholesterol;Fasting Blood Glucose;Creatinine;Myoglobin;Cardiac Troponin I;Cardiac Troponin T;B-type Natriuretic Peptide;Lactate Level;C-Reactive Protein;Procalcitonin;Cardiopulmonary Bypass Duration;Aortic Clamp Time ;Anesthesia Duration;Operation Duration;

Countries

China

Contacts

Public ContactZhang Liangqing

Guangdong Medical University Affiliated Hospital

1600661935@qq.com+86 138 2258 6877

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 9, 2026